151 related articles for article (PubMed ID: 24284041)
1. XPD gene polymorphisms and the effects of induction chemotherapy in cytogenetically normal de novo acute myeloid leukemia patients.
El-Tokhy MA; Hussein NA; Bedewy AM; Barakat MR
Hematology; 2014 Oct; 19(7):397-403. PubMed ID: 24284041
[TBL] [Abstract][Full Text] [Related]
2. Influence of XPC, XPD, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population.
Bănescu C; Iancu M; Trifa AP; Dobreanu M; Moldovan VG; Duicu C; Tripon F; Crauciuc A; Skypnyk C; Bogliș A; Lazar E
Tumour Biol; 2016 Jul; 37(7):9357-66. PubMed ID: 26779634
[TBL] [Abstract][Full Text] [Related]
3. DNA repair genes polymorphisms in multiple myeloma: no association with XRCC1 (Arg399Gln) polymorphism, but the XRCC4 (VNTR in intron 3 and G-1394T) and XPD (Lys751Gln) polymorphisms is associated with the disease in Turkish patients.
Cifci S; Yilmaz M; Pehlivan M; Sever T; Okan V; Pehlivan S
Hematology; 2011 Nov; 16(6):361-7. PubMed ID: 22183071
[TBL] [Abstract][Full Text] [Related]
4. Contribution of DNA Repair Xeroderma Pigmentosum Group D Genotypes to Colorectal Cancer Risk in Taiwan.
Chang WS; Yueh TC; Tsai CW; Ji HX; Wu CN; Wang SC; Lai YL; Hsu SW; Hsieh MH; Hsiao CL; Hung YW; Shih TC; Bau DT
Anticancer Res; 2016 Apr; 36(4):1657-63. PubMed ID: 27069143
[TBL] [Abstract][Full Text] [Related]
5. ERCC2/XPD Lys751Gln and Asp312Asn gene polymorphism and lung cancer risk: a meta-analysis involving 22 case-control studies.
Zhan P; Wang Q; Wei SZ; Wang J; Qian Q; Yu LK; Song Y
J Thorac Oncol; 2010 Sep; 5(9):1337-45. PubMed ID: 20651612
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in XPC, XPD and XPG DNA repair genes and leukemia risk in a Tunisian population.
Douzi K; Ouerhani S; Menif S; Safra I; Abbes S
Leuk Lymphoma; 2015 Jun; 56(6):1856-62. PubMed ID: 25311495
[TBL] [Abstract][Full Text] [Related]
7. XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer.
Hansen RD; Sørensen M; Tjønneland A; Overvad K; Wallin H; Raaschou-Nielsen O; Vogel U
Mutat Res; 2007 Jun; 619(1-2):68-80. PubMed ID: 17363013
[TBL] [Abstract][Full Text] [Related]
8. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
Quintela-Fandino M; Hitt R; Medina PP; Gamarra S; Manso L; Cortes-Funes H; Sanchez-Cespedes M
J Clin Oncol; 2006 Sep; 24(26):4333-9. PubMed ID: 16896002
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of the DNA repair genes XPD and XRCC1 and the risk of age-related macular degeneration.
Görgün E; Güven M; Unal M; Batar B; Güven GS; Yenerel M; Tatlipinar S; Seven M; Yüksel A
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4732-7. PubMed ID: 20375340
[TBL] [Abstract][Full Text] [Related]
10. Effect of XPD and TP53 Gene Polymorphisms on the Risk of Platinum-Based Chemotherapy Induced Toxicity in Bangladeshi Lung Cancer Patients.
Nairuz T; Bushra YU; Kabir Y
Asian Pac J Cancer Prev; 2021 Dec; 22(12):3809-3815. PubMed ID: 34967559
[TBL] [Abstract][Full Text] [Related]
11. Sequence variations in the DNA repair gene XPD and risk of lung cancer in a Chinese population.
Liang G; Xing D; Miao X; Tan W; Yu C; Lu W; Lin D
Int J Cancer; 2003 Jul; 105(5):669-73. PubMed ID: 12740916
[TBL] [Abstract][Full Text] [Related]
12. XPD Lys751Gln polymorphism in the etiology and outcome of childhood acute myeloid leukemia: a Children's Oncology Group report.
Mehta PA; Alonzo TA; Gerbing RB; Elliott JS; Wilke TA; Kennedy RJ; Ross JA; Perentesis JP; Lange BJ; Davies SM;
Blood; 2006 Jan; 107(1):39-45. PubMed ID: 16150943
[TBL] [Abstract][Full Text] [Related]
13. [Polymorphism Lys751Gln of XPD gene and breast cancer risk in women].
Romanowicz-Makowska H; Smolarz B
Pol Merkur Lekarski; 2007 Aug; 23(134):107-9. PubMed ID: 18044339
[TBL] [Abstract][Full Text] [Related]
14. The genotype distribution of the XRCC1, XRCC3, and XPD DNA repair genes and their role for the development of acute myeloblastic leukemia.
Sorour A; Ayad MW; Kassem H
Genet Test Mol Biomarkers; 2013 Mar; 17(3):195-201. PubMed ID: 23397959
[TBL] [Abstract][Full Text] [Related]
15. The influence of XPD, APE1, XRCC1, and NBS1 polymorphic variants on DNA repair in cells exposed to X-rays.
Gdowicz-Klosok A; Widel M; Rzeszowska-Wolny J
Mutat Res; 2013 Jul; 755(1):42-8. PubMed ID: 23669291
[TBL] [Abstract][Full Text] [Related]
16. A haplotype encompassing the variant allele of DNA repair gene polymorphism ERCC2/XPD Lys751Gln but not the variant allele of Asp312Asn is associated with risk of lung cancer in a northeastern Chinese population.
Yin J; Vogel U; Ma Y; Qi R; Sun Z; Wang H
Cancer Genet Cytogenet; 2007 May; 175(1):47-51. PubMed ID: 17498557
[TBL] [Abstract][Full Text] [Related]
17. Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.
Yang R; Zhang C; Malik A; Shen ZD; Hu J; Wu YH
World J Gastroenterol; 2014 Nov; 20(44):16765-73. PubMed ID: 25469049
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in XPD (Asp312Asn and Lys751Gln) genes, sunburn and arsenic-related skin lesions.
McCarty KM; Smith TJ; Zhou W; Gonzalez E; Quamruzzaman Q; Rahman M; Mahiuddin G; Ryan L; Su L; Christiani DC
Carcinogenesis; 2007 Aug; 28(8):1697-702. PubMed ID: 17470448
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of DNA repair genes XPD and XRCC1 and risk of cataract development.
Unal M; Güven M; Batar B; Ozaydin A; Sarici A; Devranoğlu K
Exp Eye Res; 2007 Sep; 85(3):328-34. PubMed ID: 17637462
[TBL] [Abstract][Full Text] [Related]
20. XPD Lys751Gln polymorphism analysis in women with sporadic breast cancer.
Romanowicz-Makowska H; Sobczuk A; Smolarz B; Fiks T; Kulig A
Pol J Pathol; 2007; 58(4):245-9. PubMed ID: 18459458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
